Cargando…

The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study

BACKGROUND: Calcium sulphate(CS) is one of the oldest alloplastic graft materials used because of its biocompatibility, handling characteristics, porosity, different rates of dissolution, chemico-physical resemblance to bone mineral, ability to induce release of growth factors and potentially unlimi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandit, Nymphea, Sharma, Aditi, Jain, Ashish, Bali, Deepika, Malik, Rajvir, Gugnani, Shalini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645542/
https://www.ncbi.nlm.nih.gov/pubmed/26644722
http://dx.doi.org/10.4103/0972-124X.156875
_version_ 1782400836142366720
author Pandit, Nymphea
Sharma, Aditi
Jain, Ashish
Bali, Deepika
Malik, Rajvir
Gugnani, Shalini
author_facet Pandit, Nymphea
Sharma, Aditi
Jain, Ashish
Bali, Deepika
Malik, Rajvir
Gugnani, Shalini
author_sort Pandit, Nymphea
collection PubMed
description BACKGROUND: Calcium sulphate(CS) is one of the oldest alloplastic graft materials used because of its biocompatibility, handling characteristics, porosity, different rates of dissolution, chemico-physical resemblance to bone mineral, ability to induce release of growth factors and potentially unlimited supply at a modest cost. Aim of the study was to evaluate the efficacy of 3 forms of calcium sulphate i.e. Nanogen (nCS)(+), BoneGen(+) and Dentogen(+) in treatment of infrabony defects and to compare their efficacy as bone grafting substitutes. MATERIALS AND METHODS: A prospective randomized, double blind controlled study was conducted on 45 sites from 16 subjects having Moderate to Advanced Periodontitis who were divided into 3 groups i.e. Group I (Nanogen), Group II (Dentogen) and Group III (BoneGen) clinical along with radiographic measurements were taken at baseline, 6 and 12 months postoperatively. RESULTS: There was no significant inter-group difference in mean clinical attachment level (CAL) values at different time intervals whereas Intra-group changes in CAL at 6 and 12 months as compared to baseline were significant statistically. In Group I, changes in CAL between 6 and 12 months were found to be statistically significant in comparison with Group II and III. CONCLUSION: Both Nanogen and BoneGen TR can be considered valuable options in the treatment of infra-bony periodontal defects. The faster degradation of Dentogen may negatively affect its bone regeneration potential.
format Online
Article
Text
id pubmed-4645542
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-46455422015-12-07 The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study Pandit, Nymphea Sharma, Aditi Jain, Ashish Bali, Deepika Malik, Rajvir Gugnani, Shalini J Indian Soc Periodontol Original Article BACKGROUND: Calcium sulphate(CS) is one of the oldest alloplastic graft materials used because of its biocompatibility, handling characteristics, porosity, different rates of dissolution, chemico-physical resemblance to bone mineral, ability to induce release of growth factors and potentially unlimited supply at a modest cost. Aim of the study was to evaluate the efficacy of 3 forms of calcium sulphate i.e. Nanogen (nCS)(+), BoneGen(+) and Dentogen(+) in treatment of infrabony defects and to compare their efficacy as bone grafting substitutes. MATERIALS AND METHODS: A prospective randomized, double blind controlled study was conducted on 45 sites from 16 subjects having Moderate to Advanced Periodontitis who were divided into 3 groups i.e. Group I (Nanogen), Group II (Dentogen) and Group III (BoneGen) clinical along with radiographic measurements were taken at baseline, 6 and 12 months postoperatively. RESULTS: There was no significant inter-group difference in mean clinical attachment level (CAL) values at different time intervals whereas Intra-group changes in CAL at 6 and 12 months as compared to baseline were significant statistically. In Group I, changes in CAL between 6 and 12 months were found to be statistically significant in comparison with Group II and III. CONCLUSION: Both Nanogen and BoneGen TR can be considered valuable options in the treatment of infra-bony periodontal defects. The faster degradation of Dentogen may negatively affect its bone regeneration potential. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4645542/ /pubmed/26644722 http://dx.doi.org/10.4103/0972-124X.156875 Text en Copyright: © Journal of Indian Society of Periodontology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Pandit, Nymphea
Sharma, Aditi
Jain, Ashish
Bali, Deepika
Malik, Rajvir
Gugnani, Shalini
The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study
title The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study
title_full The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study
title_fullStr The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study
title_full_unstemmed The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study
title_short The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study
title_sort use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: a clinical and radiographic study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645542/
https://www.ncbi.nlm.nih.gov/pubmed/26644722
http://dx.doi.org/10.4103/0972-124X.156875
work_keys_str_mv AT panditnymphea theuseofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT sharmaaditi theuseofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT jainashish theuseofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT balideepika theuseofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT malikrajvir theuseofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT gugnanishalini theuseofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT panditnymphea useofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT sharmaaditi useofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT jainashish useofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT balideepika useofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT malikrajvir useofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy
AT gugnanishalini useofnanocrystallineandtwootherformsofcalciumsulfateinthetreatmentofinfrabonydefectsaclinicalandradiographicstudy